| Date Filed | Type | Description |
| 03/06/2023 |
4
| Lieu Hsiao D (SVP, Chief Medical Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 53,000 shares
@ $0
Granted 159,000 options to buy
@ $4.36, valued at
$693.2k
|
|
| 11/08/2022 |
4
| Lieu Hsiao D (SVP, Chief Medical Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $5.36, valued at
$804k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2020 |
4
| Lieu Hsiao D (SVP, Chief Medical Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,562 shares
@ $22, valued at
$34.4k
|
|
| 05/18/2020 |
3/A
| Lieu Hsiao D (SVP, Chief Medical Officer) has filed a Form 3/A on NGM BIOPHARMACEUTICALS INC |
| 04/14/2020 |
3
| Lieu Hsiao D (SVP, Chief Medical Officer) has filed a Form 3 on NGM BIOPHARMACEUTICALS INC |
| 04/02/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2011 |
4
| Lieu Hsiao (VP, Clinical Research) has filed a Form 4 on Nile Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.78, valued at
$78k
|
|
| 01/05/2011 |
4
| Lieu Hsiao (VP, Clinical Research) has filed a Form 4 on Nile Therapeutics, Inc.|
Txns:
| Granted 27,192 options to buy
@ $1.14, valued at
$31k
|
|
| 12/21/2010 |
4
| Lieu Hsiao (VP, Clinical Research) has filed a Form 4 on Nile Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.45, valued at
$111.3k
|
|
| 07/12/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/21/2010 |
4
| Lieu Hsiao (VP, Clinical Research) has filed a Form 4 on Nile Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $4.45, valued at
$55.6k
|
|
| 07/20/2009 |
3
| Lieu Hsiao (VP, Clinical Research) has filed a Form 3 on Nile Therapeutics, Inc. |